• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AT1
Click for more information
3.33% 3.1¢

ATOMO DIAGNOSTICS LIMITED - Charts / Financials

Market Cap $19.81M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Atomo Diagnostics Limited is an Australia-based medical device company. The Company... Atomo Diagnostics Limited is an Australia-based medical device company. The Company supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiation and female health. Its products include Atomo HIV Self-Test, AtomoRapid HIV (1&2) and ATOMONOW Pregnancy Test. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. Its AtomoRapid HIV (1&2) integrates multiple test components into the device platform. AtomoRapid HIV (1&2) needs a small drop of blood to give results in 15 minutes.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 03/05/2024 (20 minute delay) ?
Day
Open 3.0¢   Day High 3.1¢   Day Low 2.9¢
Daily Volume 159655
Bids   Sellers
Number Price Volume   Number Price Volume
1 3.0¢ 123968   2 3.1¢ 53324

Directors & Senior Management

Mr. John Kelly Chief Executive Officer, Founder, Managing Director, Director
Mr. Chandra Sukumar Chief Operating Officer
Ms. Sally Mcdow Company Secretary
Mr. John Keith Non-Executive Chairman of the Board
Dr. Paul Kasian Non-Executive Director
Dr. Curt H. LaBelle Non-Executive Director
Ms. Deborah J. Neff Non-Executive Independent Director
Dr. Cheri Walker Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
3.1¢ 		Change
0.001(3.33%) 		Mkt cap ! $19.81M
Open High Low Value Volume
3.0¢ 3.1¢ 2.9¢ $4.745K 159.6K

Buyers (Bids)

No. Vol. Price($)
1 123968 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 53324 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
3.1¢ 		  Change
0.001 ( 3.33 %)
Open High Low Volume
3.0¢ 3.1¢ 2.9¢ 32795
Last updated 15.59pm 03/05/2024 ?

Top Stories

Why Princeton Professor rates BlinkLab's autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Infini Resources gearing up for UAV geophys survey over Portland Creek Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland Creek Uranium Project.
Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments' Macquarie Group Ltd (ASX:MQG) has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green in...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.